High-grade prostate cancer is associated with low serum testosterone levels

Prostate

Volumn 47, Issue 1, 2001, Pages 52-58

  Schatzl, Georg ^a   Madersbacher, Stephan ^a   Thurridl, Thomas ^a   Waldmüller, Julia ^a   Kramer, Gero ^a   Haitel, Andrea ^a   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Androgen deficiency; Estrogen; Gleason score; Prostate cancer; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; HORMONE DEFICIENCY; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RECEPTOR DENSITY; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; DEHYDROEPIANDROSTERONE; ESTRADIOL; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TESTOSTERONE;

EID: 0035313592     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1046     Document Type: Article

References (20)

1. What causes prostate cancer? A brief summary of the epidemiology
2. Genetic and environmental factors in prostate cancer genesis: Identifying high- risk cohorts
3. Carcinoma of the prostate: Relationship of pretreatment hormone levels to survival
4. Prediagnostic serum hormones and the risk of prostate cancer
5. Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer - A population-based case-control study
6. Pretreatment plasma testosterone and estradiol levels in patients with locally advanced or metastasized prostatic cancer
7. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
8. Prospective study of sex hormone levels and risk of prostate cancer
9. Age, middle, and changing sex hormone levels in middle-aged men: Results of the Massachusetts male aging study
10. Endocrine status in elderly men with lower urinary tract symptoms: Correlation of age, hormonal status, and LUTS function
11. Occult prostate cancer in men with low serum testosterone levels
12. Is low serum free testosterone a marker for high grade prostate cancer?
13. Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection
14. Histological grading and clinical staging of prostate cancer
15. Prognostic factors in survival free progression after androgen deprivation therapy for treatment of prostate cancer
16. Low testosterone and a younger age predict a poor outcome in metastatic prostate cancer
17. Endocrine patterns in patients with benign and malignant prostatic disease
18. Influence of radical prostatectomy on serum hormone levels
19. Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma
20. Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells